Ergostatrien-3β-ol from antrodia camphorata inhibits diabetes and hyperlipidemia in high-fat-diet treated mice via regulation of hepatic related genes, glucose transporter 4, and AMP-activated protein kinase phosphorylation

Journal of Agricultural and Food Chemistry

Volumn 63, Issue 9, 2015, Pages 2479-2489

  Kuo, Yueh Hsiung ^a,b   Lin, Cheng Hsiu ^c   Shih, Chun Ching ^d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c Ministry of Health and Welfare   (Taiwan)

^d CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

AMP activated protein kinase phosphorylation; Antrodia camphorata; diabetes; glucose transporter 4; hypercholesterolemia; hyperlipidemia

Indexed keywords

BIOSYNTHESIS; BLOOD; CHOLESTEROL; CYTOLOGY; ENZYMES; FATTY ACIDS; GLUCOSE; INSULIN; LIPOPROTEINS; MEDICAL PROBLEMS; MUSCLE; PHOSPHORYLATION;

AMP-ACTIVATED PROTEIN KINASE; ANTRODIA CAMPHORATA; GLUCOSE TRANSPORTER 4; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA;

MAMMALS;

MUS; TAIWANOFUNGUS CAMPHORATUS;

ERGOSTATRIEN-3-OL; ERGOSTEROL; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORTER 4; HERBACEOUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; TRIACYLGLYCEROL;

ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTRODIA; C57BL MOUSE; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIAS; LIPID DIET; LIVER; MALE; METABOLISM; MOUSE; PHOSPHORYLATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTRODIA; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DRUGS, CHINESE HERBAL; ERGOSTEROL; GLUCOSE TRANSPORTER TYPE 4; HUMANS; HYPERLIPIDEMIAS; LIVER; MALE; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; TRIGLYCERIDES;

EID: 84924559848     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.5b00073     Document Type: Article

References (42)

1. ORahilly, S.; Turner, R. C.; Matthews, D. R. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes N. Engl. J. Med. 1988, 318, 1225-1230
2. Thresher, J. S.; Podolin, D. A.; Wei, Y.; Mazzeo, R. S.; Pagliassotti, M. J. Comparison of the effects of sucrose and fructose on insulin action and glucose tolerance Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279, R1334-R1340
3. Geethangili, M.; Tzeng, Y. M. Review of pharmacological effects of Antrodia camphorata and its bioactive compounds Evidence-Based Compl. Altern. Med. 2011, 2011, No. 212641
4. Yeh, C. T.; Rao, Y. K.; Yao, C. J.; Yeh, C. F.; Li, C. H.; Chuang, S. E.; Luong, J. H.; Lai, G. M.; Tzeng, Y. M. Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells Cancer Lett. 2009, 285, 73-79
5. Huang, G. J.; Huang, S. S.; Lin, S. S.; Shao, Y. Y.; Chen, C. C.; Hou, W. C. Analgesic effects and the mechanisms of anti-inflammation of ergostatrien-3beta-ol from Antrodia camphorata submerged whole broth in mice J. Agric. Food Chem. 2010, 58, 7445-7452
6. 2+-NO-cAMP pathway Life Sci. 2003, 73, 2769-2783
7. 4-induced hepatic toxicity in rats J. Agric. Food Chem. 2003, 51, 1571-1577
8. Huang, S.; Czech, M. P. The GLUT4 glucose transporter Cell Metab. 2007, 5, 237-252
9. Bryant, N. J.; Govers, R.; James, D. E. Regulated transport of the glucose transporter GLUT4 Nat. Rev. Mol. Cell Biol. 2002, 3, 267-277
10. Watson, R. T.; Pessin, J. E. Intracellular organization of insulin signaling and GLUT4 translocation Recent Prog. Horm. Res. 2001, 56, 175-193
11. Zhou, G.; Myers, R.; Li, Y.; Chen, Y.; Shen, X.; Fenyk-Melody, J.; Wu, M.; Ventre, J.; Doebber, T.; Fujii, N.; Musi, N.; Hirshman, M. F.; Goodyear, L. J.; Möller, D. E. Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 2001, 108, 1167-1174
12. Musi, N.; Hirshman, M. F.; Nygren, J.; Svanfeldt, M.; Bavenholm, P.; Rooyackers, O.; Zhou, G.; Williamson, J. M.; Ljunqvist, O.; Efendic, S.; Möller, D. E.; Thorell, A.; Goodyear, L. J. Metformin increases AMP-activated protein kinase activity in skeletal muscle od subjects with type 2 diabetes Diabetes 2002, 51, 2074-2081
13. Rangwala, S. M.; Lazar, M. A. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. PPAR gamma, glucose homeostasis Trends Pharmacol. Sci. 2004, 25, 331-336 Review.
14. Martinez, L.; Berenguer, M.; Bruce, M. C.; Le Marchand-Brustel, Y.; Govers, R. Rosiglitazone increases cell surface GLUT4 levels in 3T3-L1 adipocytes through an enhacement of endosomal recycling Biochem. Pharmacol. 2010, 79, 1300-1309
15. Kersten, S.; Desvergne, B.; Wahli, W. Roles of PPARs in health and disease Nature 2000, 405, 421-424
16. Farnier, M.; Bonnefous, F.; Debbas, N.; Irvine, A. Comparative efficacy and safety of micronised fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia Arch. Int. Med. 1994, 154, 441-449
17. Srivastava, R. A. K.; Jahagirdar, R.; Azhar, S.; Sharma, S.; Bisgaier, C. L. Peroxisome proliferator-activated receptor-α - selective ligand reduces adiposity, improves insulin sensitivity, and inhibits atherosclerosis in LDL receptor-deficient mice Mol. Cell. Biochem. 2006, 285, 35-50
18. Winzell, M. S.; Ahrèn, B. The high-fat diet mouse: a model for studying mechanisms and type 2 diabetes Diabetes 2004, 53 (Suppl. 3) S215-219
19. Petro, A. E.; Cotter, J.; Cooper, D. A.; Peters, J. C.; Surwit, S. J.; Surwit, R. S. Fat, carbohydrate and calories in the development of diabetes and obesity in the C57BL/6J mouse Metabolism 2004, 53, 454-457
20. Viollet, B.; Guigas, B.; Sanz Garcia, N.; Leclerc, J.; Foretz, M.; Andreelli, F. Cellular and molecular mechanisms of metformin: an overview Clin. Sci. (London) 2012, 122, 253-270
21. Fryer, L. G.; Parbu-Patel, A.; Patel, A. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways J. Biol. Chem. 2002, 277, 25226-25232
22. Stein, S. C.; Woods, A.; Jones, N. A.; Davison, M. D.; Carling, D. The regulation of AMP-activated protein kinase by phosphorylation Biochem. J. 2000, 345, 437-443
23. Shao, Y. Y.; Chen, C. C.; Wang, H. Y.; Chiu, H. L.; Hseu, T. H.; Kuo, Y. H. Chemical constituents of Antrodia camphorata submerged whole broth Nat. Prod. Res. 2008, 22, 1151-1157
24. Shih, C. C.; Lin, C. H.; Lin, W. L. Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet Diabetes Res. Clin. Pract. 2008, 81, 134-143
25. Shih, C. C.; Lin, C. H.; Wu, J. B. Eriobotrya japonica improves hyperlipidaemia and reverses insulin resistance in high-fat-fed mice Phytother. Res. 2010, 24, 1769-1780
26. Shih, C. C.; Ciou, J. L.; Lin, C. H.; Wu, J. B.; Ho, H. Y. Cell suspension culture of Eriobotrya japonica regulates the diabetic and hyperlipidemic signs of high-fat-fed mice Molecules 2013a, 18, 2726-2753
27. Wu, J. B.; Kuo, Y. H.; Lin, C. H.; Ho, Y. H.; Shih, C. C. Tormentic acid, a major component of suspension cells of Eriobotrya japonica, suppresses high-fat diet-induced diabetes and hyperlipidemia by glucose transporter 4 and AMP-activated protein kinase phosphorylation J. Agric. Food Chem. 2014, 62, 10717-10726
28. Shih, C. C.; Lin, C. H.; Lin, W. L.; Wu, J. B. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats J. Ethnopharmacol. 2009, 123, 82-90
29. Damci, T.; Tatliagac, S.; Osar, Z.; Ilkova, H. Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia Eur. J. Inter. Med. 2003, 14, 357-360
30. George, S.; Rochford, J. J.; Wolfrum, C. A family with severe insulin resistance and diabetes due to a mutation in AKT2 Science 2004, 304, 1325-1328
31. Berg, J. M.; Tymoczko, J. L.; Stryer, L. Glycolysis and glyconeogenesis. In Stryer Biochemistry; Berg, J. M.; Tymoczko, J. L., Eds.; Freeman: New York, 2001; pp 425-464.
32. Mithieux, G.; Guignot, L.; Bordet, J. C.; Wiernsperger, N. Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet Diabetes 2002, 51, 139-143
33. Staels, B.; Dallongeville, J.; Auwerx, J.; Schoonjans, K.; Leitersdorf, E.; Fruchart, J.-C. Mechanism of action of fibrates on lipid and lipoprotein metabolism Circulation 1998, 98, 2088-2093
34. Shimano, H.; Yahagi, N.; Amemiya-Kudo, M.; Hasty, A. H.; Osuga, J.; Tamura, Y.; Shionoiri, F.; Iizuka, Y.; Ohashi, K.; Harada, K.; Gotoda, T.; Ishibashi, S.; Yamada, N. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes J. Biol. Chem. 1999, 274, 35832-35839
35. Patel, D. D.; Knight, B. L.; Wiggins, D.; Humphreys, S. M.; Gibbons, G. F. Disturbances in the normal regulation of SREBP-sensitive genes in PPAR alpha-deficient mice J. Lipid Res. 2001, 42, 328-337
36. Cases, S.; Stone, S. J.; Zhou, P.; Yen, E.; Tow, B.; Lardizabal, K. D.; Voelker, T.; Farese, R. V., Jr. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members J. Biol. Chem. 2001, 276, 38870-38876
37. Izumiya, Y.; Hopkins, T.; Morris, C.; Sato, K.; Zeng, L.; Viereck, J.; Hamilton, J. A.; Ouchi, N.; LeBrasseur, N. K.; Walsh, K. Fast/ Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice Cell Metab. 2008, 7, 159-172
38. Srivastava, R. A. K. Fenofibrate ameliorates diabetic and dyslipidemic profiles in KKAy mice partly via down-regulation of 11β-HSD1, PEPCK and DGAT2. Comparison of PPARα, PPARγ, and liver x receptor agonists Eur. J. Pharmacol. 2009, 607, 258-263
39. Shimano, H.; Shimomura, I.; Hammer, R. E.; Herz, J.; Goldstein, J. L.; Brown, M. S.; Horton, J. D. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene J. Clin. Invest. 1997, 100, 2115-2124
40. Staeles, B.; Fruchart, J. C. Therapeutic roles of peroxisome proliferator-activated receptor agonists Diabetes 2005, 54, 2460-2470
41. Eggerman, T. L.; Hoeg, J. M.; Meng, M. S.; Tombragel, A.; Bojanovski, D.; Brewer, H. B., Jr. Differential tissue-specific expression of human apoA-I and apoA-II J. Lipid Res. 1991, 32, 821-828
42. Gordon, D. J.; Probstfield, J. L.; Garrison, R. J.; Neaton, J. D.; Castelli, W. P.; Knoke, J. D.; Jacobs, D. R., Jr.; Bangdiwala, S.; Tyroler, H. A. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies Circulation 1989, 79, 8-15